Antibiotic administration in targeted nanoparticles protects the faecal microbiota of mice

dc.authoridÖzalp, Veli Cengiz/0000-0002-7659-5990
dc.authoridAcuner, Ibrahim Cagatay/0000-0001-5790-2273
dc.authoridKavruk, Murat/0000-0001-5331-7253
dc.authorscopusid55946080400
dc.authorscopusid24921796800
dc.authorscopusid57191821696
dc.authorscopusid57222668863
dc.authorscopusid57211791524
dc.authorscopusid23494749600
dc.authorscopusid55279809300
dc.authorwosidÖzalp, Veli Cengiz/B-2940-2009
dc.authorwosidAcuner, Ibrahim Cagatay/L-4693-2019
dc.authorwosidAcuner, Ibrahim Cagatay/ABA-8408-2021
dc.authorwosidBarış, Işık İkbal/JAN-4583-2023
dc.authorwosidKavruk, Murat/O-6694-2016
dc.contributor.authorÖzalp, Veli Cengiz
dc.contributor.authorSudagidan, Mert
dc.contributor.authorAldag, Mehmet E.
dc.contributor.authorBaris, Isik I.
dc.contributor.authorAcar, Elif E.
dc.contributor.authorAcuner, Cagatay
dc.contributor.authorOzalp, Veli C.
dc.contributor.otherBasic Sciences
dc.date.accessioned2024-07-05T15:19:34Z
dc.date.available2024-07-05T15:19:34Z
dc.date.issued2021
dc.departmentAtılım Universityen_US
dc.department-temp[Borsa, Baris A.] Linkoping Univ, Dept Phys Chem & Biol IFM, Nucle Acid Technol Lab, SE-58183 Linkoping, Sweden; [Sudagidan, Mert; Acar, Elif E.] Konya Food & Agr Univ, Kit Argem Res Ctr, TR-42080 Meram, Konya, Turkey; [Aldag, Mehmet E.] Corlu State Hosp, Dept Med Microbiol, Tekirdag, Turkey; [Baris, Isik I.] Cakmak Erdem Hosp, Dept Pathol, Istanbul, Turkey; [Acuner, Cagatay] Yeditepe Univ, Med Sch, Dept Med Microbiol, Istanbul, Turkey; [Kavruk, Murat] Turkish Stand Inst TSE, Test & Calibrat Ctr, TR-41400 Kocaeli, Turkey; [Ozalp, Veli C.] Atilim Univ, Med Sch, Dept Med Biol, TR-06830 Ankara, Turkeyen_US
dc.descriptionÖzalp, Veli Cengiz/0000-0002-7659-5990; Acuner, Ibrahim Cagatay/0000-0001-5790-2273; Kavruk, Murat/0000-0001-5331-7253en_US
dc.description.abstractAntibiotic therapy comes with disturbances on human microbiota, resulting in changes of bacterial communities and thus leading to well-established health problems. In this study, we demonstrated that targeted teicoplanin administration maintains the faecal microbiota composition undisturbed in a mouse model while reaching therapeutic improvements for S. aureus infection.en_US
dc.identifier.citation6
dc.identifier.doi10.1039/d0md00347f
dc.identifier.endpage383en_US
dc.identifier.issn2632-8682
dc.identifier.issue3en_US
dc.identifier.pmid34046621
dc.identifier.scopus2-s2.0-85103700830
dc.identifier.startpage380en_US
dc.identifier.urihttps://doi.org/10.1039/d0md00347f
dc.identifier.urihttps://hdl.handle.net/20.500.14411/1988
dc.identifier.volume12en_US
dc.identifier.wosWOS:000635760100005
dc.language.isoenen_US
dc.publisherRoyal Soc Chemistryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keyword Available]en_US
dc.titleAntibiotic administration in targeted nanoparticles protects the faecal microbiota of miceen_US
dc.typeArticleen_US
dspace.entity.typePublication
relation.isAuthorOfPublication5698576b-38e7-4cc8-9551-3e06cf62ede8
relation.isAuthorOfPublication.latestForDiscovery5698576b-38e7-4cc8-9551-3e06cf62ede8
relation.isOrgUnitOfPublicationc6d3b3b7-f103-4779-9789-92b2e2420f2d
relation.isOrgUnitOfPublication.latestForDiscoveryc6d3b3b7-f103-4779-9789-92b2e2420f2d

Files

Collections